Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer, OrbiMed back $40M Rhythm round for rare genetic disease R&D
Pfizer, OrbiMed back $40M Rhythm round for rare genetic disease R&D
Pfizer, OrbiMed back $40M Rhythm round for rare genetic disease R&D
Submitted by
admin
on August 16, 2015 - 10:30am
Source:
Fierce Biotech
News Tags:
Pfizer
OrbiMed
Rhythm Pharmaceuticals
Prader-Willi Syndrome
Headline:
Pfizer, OrbiMed back $40M Rhythm round for rare genetic disease R&D
Do Not Allow Advertisers to Use My Personal information
